Skip to content Skip to footer
Subscribe Now
VIEWPOINTS_Nathan McCutcheon_2023
VIEWPOINTS

Nathan McCutcheon shares highlights of Qpex Biopharma’s acquisition by Shionogi

Shots:  Nathan McCutcheon, President, and Chief Executive Officer of Shionogi, shares the highlights of the recent acquisition of Qpex Biopharma by Shionogi   Nathan believes that Qpex’s specialized expertise and extensive experience in chemistry and molecular design are sure to strengthen and be useful for the combined antibiotic pipeline   The acquisition provides Shionogi exclusive development, manufacturing,…
October 16, 2023

Read more

Webinar Recap Beyond the Horizon Exploring Competitive Insights in the Life Science and Pharma Sectors
EVENTS

Webinar Recap: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

Intuitive, informative, and gripping, could be an articulate three-word summarization of our recent webinar on Competitive Intelligence. October 5th, 2023, the day PharmaShots organized a webinar dedicated to competitive intelligence and navigated the nuances that go beyond the conventional definition of CI. Titled "Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma…
October 11, 2023

Read more

Thoughtspot_Saurabh_Chaubey
THOUGHTSPOT

Health Equity: A Pressing Need

Shots:  With half of the World's population devoid of primary healthcare facilities, health equity is indeed an indispensable need of the present. With health equity instated, potentially everyone can attain the highest level of health. It means no more deaths from vaccine-preventable diseases, and a healthy equilibrium in the physical, mental, and social aspects of…
October 10, 2023

Read more

VIEWPOINTS_Robert Connelly_2023
VIEWPOINTS

Robert Connelly shares the highlights of the post-merger between Elicio Therapeutics & Angion Biomedica Corp.

Shots:  Robert Connelly, CEO of Elicio Therapeutics, shared his views on the aftermath of the merger between Elicio Therapeutics & Angion Biomedica Corp. The strategic merger is instrumental to further advance Elicio’s product candidates with a focus on advancing its proprietary lymph node targeting Amphiphile (AMP) technology to develop immunotherapies  Robert recapitulates data presented at ASCO…
October 9, 2023

Read more

VIEWPOINTS_Samantha Kerr_2023
VIEWPOINTS

Samantha Kerr shares insights from the topline data of Xeomin P-III studies and pivotal study evaluating Belotero Balance (+)

Shots: Samantha Kerr, Chief Scientific Officer, Merz Aesthetics shares insights from the topline data of Xeomin P-III studies and pivotal study evaluating Belotero Balance (+) Samantha says, for Belotero Balance (+), Merz Aesthetics has already submitted the data as a supplemental Premarket Approval Application (sPMA) with the FDA and plans to submit the data as…
October 5, 2023

Read more

VIEWPOINTS_Sergey Yurasov_2023
VIEWPOINTS

Sergey Yurasov Shares Insights on Initial Dose Escalation Data of BDTX-1535 for the Treatment of Non-Small Cell Lung Cancer Patients

Shots:   During the initial part of conversation, Sergey discussed details about the BDTX-1535 and the trial design of the P-I study where 1535 is being investigated in NSCLC and GBM patients   He then discussed the insights drawn from the first 51 patients recruited in the dose escalation part of the P-I study  In the final…
October 3, 2023

Read more

Thoughtspot_Saurabh_Chaubey
THOUGHTSPOT

Flexible Manufacturing in Pharma with CDMOs

Shots:  Pharmaceutical manufacturing involves complex procedures like blending, compression, filtration, heating, encapsulation, shearing, tableting, granulation, coating, and drying. Traditionally, for all these processes, pharma companies had designated factory floors to carry out the process smoothly  The flexible manufacturing system (FMS) revolutionized the course of manufacturing, especially in the pharma industry. Contract Development Manufacturing Organizations' (CDMOs)…
September 12, 2023

Read more

Load more